Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    357213 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Efalizumab;   Device: Narrow Band Phototherapy
2 Active, not recruiting Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis
Conditions: Psoriasis;   Vascular Inflammation;   Coronary Atherosclerosis
Interventions: Biological: Adalimumab;   Other: Placebo
3 Recruiting Evaluation of Spa Therapy in the Treatment of Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Other: Immediate spa treatment;   Other: Late Spa treatment

Indicates status has not been verified in more than two years